nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminoglutethimide—CYP19A1—Paclitaxel—kidney cancer	0.176	0.253	CbGbCtD
Aminoglutethimide—CYP3A4—Everolimus—kidney cancer	0.0962	0.138	CbGbCtD
Aminoglutethimide—CYP1A2—Pazopanib—kidney cancer	0.0651	0.0937	CbGbCtD
Aminoglutethimide—CYP3A4—Temsirolimus—kidney cancer	0.065	0.0935	CbGbCtD
Aminoglutethimide—CYP1A2—Erlotinib—kidney cancer	0.0465	0.0669	CbGbCtD
Aminoglutethimide—CYP2C19—Sorafenib—kidney cancer	0.041	0.0589	CbGbCtD
Aminoglutethimide—CYP1A2—Sorafenib—kidney cancer	0.0378	0.0544	CbGbCtD
Aminoglutethimide—CYP3A4—Pazopanib—kidney cancer	0.0341	0.0491	CbGbCtD
Aminoglutethimide—CYP3A4—Erlotinib—kidney cancer	0.0244	0.035	CbGbCtD
Aminoglutethimide—CYP3A4—Paclitaxel—kidney cancer	0.0223	0.0321	CbGbCtD
Aminoglutethimide—CYP3A4—Sorafenib—kidney cancer	0.0198	0.0285	CbGbCtD
Aminoglutethimide—CYP3A4—Vinblastine—kidney cancer	0.0196	0.0281	CbGbCtD
Aminoglutethimide—CYP3A4—Vincristine—kidney cancer	0.0192	0.0277	CbGbCtD
Aminoglutethimide—CYP3A4—Sunitinib—kidney cancer	0.016	0.0231	CbGbCtD
Aminoglutethimide—Alveolitis allergic—Temsirolimus—kidney cancer	0.013	0.0607	CcSEcCtD
Aminoglutethimide—CYP3A4—Doxorubicin—kidney cancer	0.012	0.0173	CbGbCtD
Aminoglutethimide—Adrenal insufficiency—Sunitinib—kidney cancer	0.0101	0.0469	CcSEcCtD
Aminoglutethimide—Hypothyroidism—Pazopanib—kidney cancer	0.00498	0.0232	CcSEcCtD
Aminoglutethimide—Hirsutism—Everolimus—kidney cancer	0.00434	0.0203	CcSEcCtD
Aminoglutethimide—Hirsutism—Erlotinib—kidney cancer	0.00419	0.0196	CcSEcCtD
Aminoglutethimide—Hepatotoxicity—Pazopanib—kidney cancer	0.00414	0.0193	CcSEcCtD
Aminoglutethimide—Haematocrit decreased—Paclitaxel—kidney cancer	0.0038	0.0177	CcSEcCtD
Aminoglutethimide—Hypothyroidism—Sorafenib—kidney cancer	0.00341	0.0159	CcSEcCtD
Aminoglutethimide—Hypothyroidism—Sunitinib—kidney cancer	0.00328	0.0153	CcSEcCtD
Aminoglutethimide—Hepatotoxicity—Erlotinib—kidney cancer	0.00315	0.0147	CcSEcCtD
Aminoglutethimide—Hepatotoxicity—Sunitinib—kidney cancer	0.00273	0.0127	CcSEcCtD
Aminoglutethimide—Hepatotoxicity—Dactinomycin—kidney cancer	0.00258	0.0121	CcSEcCtD
Aminoglutethimide—Hepatotoxicity—Gemcitabine—kidney cancer	0.00219	0.0102	CcSEcCtD
Aminoglutethimide—Hirsutism—Capecitabine—kidney cancer	0.002	0.00933	CcSEcCtD
Aminoglutethimide—Neutropenia—Temsirolimus—kidney cancer	0.00199	0.00929	CcSEcCtD
Aminoglutethimide—Haemolytic anaemia—Erlotinib—kidney cancer	0.00196	0.00914	CcSEcCtD
Aminoglutethimide—Neutropenia—Pazopanib—kidney cancer	0.00187	0.00875	CcSEcCtD
Aminoglutethimide—Hypothyroidism—Capecitabine—kidney cancer	0.00181	0.00845	CcSEcCtD
Aminoglutethimide—Pancytopenia—Vinblastine—kidney cancer	0.00151	0.00704	CcSEcCtD
Aminoglutethimide—Hepatotoxicity—Capecitabine—kidney cancer	0.0015	0.00702	CcSEcCtD
Aminoglutethimide—Pancytopenia—Everolimus—kidney cancer	0.0015	0.00702	CcSEcCtD
Aminoglutethimide—Neutropenia—Everolimus—kidney cancer	0.00148	0.00691	CcSEcCtD
Aminoglutethimide—Neutropenia—Erlotinib—kidney cancer	0.00143	0.00667	CcSEcCtD
Aminoglutethimide—Anaemia—Temsirolimus—kidney cancer	0.00137	0.0064	CcSEcCtD
Aminoglutethimide—Leukopenia—Temsirolimus—kidney cancer	0.00133	0.0062	CcSEcCtD
Aminoglutethimide—Agranulocytosis—Vinblastine—kidney cancer	0.00132	0.00617	CcSEcCtD
Aminoglutethimide—Anaemia—Pazopanib—kidney cancer	0.00129	0.00603	CcSEcCtD
Aminoglutethimide—Neutropenia—Sorafenib—kidney cancer	0.00128	0.006	CcSEcCtD
Aminoglutethimide—Myalgia—Temsirolimus—kidney cancer	0.00126	0.00589	CcSEcCtD
Aminoglutethimide—Pancytopenia—Sunitinib—kidney cancer	0.00126	0.00586	CcSEcCtD
Aminoglutethimide—Leukopenia—Pazopanib—kidney cancer	0.00125	0.00584	CcSEcCtD
Aminoglutethimide—Neutropenia—Sunitinib—kidney cancer	0.00124	0.00577	CcSEcCtD
Aminoglutethimide—Myalgia—Pazopanib—kidney cancer	0.00119	0.00555	CcSEcCtD
Aminoglutethimide—Pancytopenia—Dactinomycin—kidney cancer	0.00119	0.00555	CcSEcCtD
Aminoglutethimide—Neutropenia—Dactinomycin—kidney cancer	0.00117	0.00546	CcSEcCtD
Aminoglutethimide—Anorexia—Temsirolimus—kidney cancer	0.00115	0.00539	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Temsirolimus—kidney cancer	0.0011	0.00515	CcSEcCtD
Aminoglutethimide—Anorexia—Pazopanib—kidney cancer	0.00109	0.00507	CcSEcCtD
Aminoglutethimide—Somnolence—Temsirolimus—kidney cancer	0.00108	0.00502	CcSEcCtD
Aminoglutethimide—Pancytopenia—Vincristine—kidney cancer	0.00106	0.00496	CcSEcCtD
Aminoglutethimide—Decreased appetite—Temsirolimus—kidney cancer	0.00105	0.00491	CcSEcCtD
Aminoglutethimide—Neutropenia—Vincristine—kidney cancer	0.00105	0.00488	CcSEcCtD
Aminoglutethimide—Agranulocytosis—Dactinomycin—kidney cancer	0.00104	0.00486	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Pazopanib—kidney cancer	0.00104	0.00485	CcSEcCtD
Aminoglutethimide—Anaemia—Vinblastine—kidney cancer	0.00102	0.00478	CcSEcCtD
Aminoglutethimide—Anaemia—Everolimus—kidney cancer	0.00102	0.00476	CcSEcCtD
Aminoglutethimide—Somnolence—Pazopanib—kidney cancer	0.00101	0.00473	CcSEcCtD
Aminoglutethimide—Pancytopenia—Gemcitabine—kidney cancer	0.00101	0.0047	CcSEcCtD
Aminoglutethimide—Neutropenia—Gemcitabine—kidney cancer	0.000992	0.00463	CcSEcCtD
Aminoglutethimide—Leukopenia—Vinblastine—kidney cancer	0.000991	0.00463	CcSEcCtD
Aminoglutethimide—Decreased appetite—Pazopanib—kidney cancer	0.000991	0.00463	CcSEcCtD
Aminoglutethimide—Leukopenia—Everolimus—kidney cancer	0.000987	0.00461	CcSEcCtD
Aminoglutethimide—Body temperature increased—Temsirolimus—kidney cancer	0.000957	0.00447	CcSEcCtD
Aminoglutethimide—Myalgia—Everolimus—kidney cancer	0.000939	0.00438	CcSEcCtD
Aminoglutethimide—Haemolytic anaemia—Capecitabine—kidney cancer	0.000934	0.00436	CcSEcCtD
Aminoglutethimide—Myalgia—Erlotinib—kidney cancer	0.000906	0.00423	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Temsirolimus—kidney cancer	0.000892	0.00416	CcSEcCtD
Aminoglutethimide—Anaemia—Sorafenib—kidney cancer	0.000885	0.00413	CcSEcCtD
Aminoglutethimide—Agranulocytosis—Gemcitabine—kidney cancer	0.000883	0.00412	CcSEcCtD
Aminoglutethimide—Tachycardia—Everolimus—kidney cancer	0.000879	0.0041	CcSEcCtD
Aminoglutethimide—Anorexia—Vinblastine—kidney cancer	0.000861	0.00402	CcSEcCtD
Aminoglutethimide—Anorexia—Everolimus—kidney cancer	0.000858	0.00401	CcSEcCtD
Aminoglutethimide—Leukopenia—Sorafenib—kidney cancer	0.000857	0.004	CcSEcCtD
Aminoglutethimide—Pruritus—Temsirolimus—kidney cancer	0.000856	0.004	CcSEcCtD
Aminoglutethimide—Anaemia—Sunitinib—kidney cancer	0.000852	0.00398	CcSEcCtD
Aminoglutethimide—Pancytopenia—Paclitaxel—kidney cancer	0.000844	0.00394	CcSEcCtD
Aminoglutethimide—Hypotension—Everolimus—kidney cancer	0.000841	0.00393	CcSEcCtD
Aminoglutethimide—Neutropenia—Paclitaxel—kidney cancer	0.000831	0.00388	CcSEcCtD
Aminoglutethimide—Anorexia—Erlotinib—kidney cancer	0.000828	0.00386	CcSEcCtD
Aminoglutethimide—Leukopenia—Sunitinib—kidney cancer	0.000825	0.00385	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Everolimus—kidney cancer	0.00082	0.00383	CcSEcCtD
Aminoglutethimide—Myalgia—Sorafenib—kidney cancer	0.000815	0.00381	CcSEcCtD
Aminoglutethimide—Pruritus—Pazopanib—kidney cancer	0.000807	0.00377	CcSEcCtD
Aminoglutethimide—Anaemia—Dactinomycin—kidney cancer	0.000806	0.00376	CcSEcCtD
Aminoglutethimide—Somnolence—Everolimus—kidney cancer	0.0008	0.00374	CcSEcCtD
Aminoglutethimide—Dizziness—Temsirolimus—kidney cancer	0.0008	0.00374	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.000791	0.00369	CcSEcCtD
Aminoglutethimide—Decreased appetite—Vinblastine—kidney cancer	0.000786	0.00367	CcSEcCtD
Aminoglutethimide—Myalgia—Sunitinib—kidney cancer	0.000784	0.00366	CcSEcCtD
Aminoglutethimide—Decreased appetite—Everolimus—kidney cancer	0.000783	0.00365	CcSEcCtD
Aminoglutethimide—Leukopenia—Dactinomycin—kidney cancer	0.000781	0.00364	CcSEcCtD
Aminoglutethimide—Vomiting—Temsirolimus—kidney cancer	0.000769	0.00359	CcSEcCtD
Aminoglutethimide—Rash—Temsirolimus—kidney cancer	0.000763	0.00356	CcSEcCtD
Aminoglutethimide—Dermatitis—Temsirolimus—kidney cancer	0.000762	0.00356	CcSEcCtD
Aminoglutethimide—Headache—Temsirolimus—kidney cancer	0.000758	0.00354	CcSEcCtD
Aminoglutethimide—Decreased appetite—Erlotinib—kidney cancer	0.000755	0.00352	CcSEcCtD
Aminoglutethimide—Dizziness—Pazopanib—kidney cancer	0.000754	0.00352	CcSEcCtD
Aminoglutethimide—Anorexia—Sorafenib—kidney cancer	0.000745	0.00348	CcSEcCtD
Aminoglutethimide—Myalgia—Dactinomycin—kidney cancer	0.000743	0.00347	CcSEcCtD
Aminoglutethimide—Vomiting—Pazopanib—kidney cancer	0.000725	0.00338	CcSEcCtD
Aminoglutethimide—Anaemia—Vincristine—kidney cancer	0.00072	0.00336	CcSEcCtD
Aminoglutethimide—Rash—Pazopanib—kidney cancer	0.000719	0.00336	CcSEcCtD
Aminoglutethimide—Nausea—Temsirolimus—kidney cancer	0.000719	0.00336	CcSEcCtD
Aminoglutethimide—Dermatitis—Pazopanib—kidney cancer	0.000718	0.00335	CcSEcCtD
Aminoglutethimide—Anorexia—Sunitinib—kidney cancer	0.000717	0.00335	CcSEcCtD
Aminoglutethimide—Headache—Pazopanib—kidney cancer	0.000714	0.00333	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000712	0.00332	CcSEcCtD
Aminoglutethimide—Body temperature increased—Everolimus—kidney cancer	0.000712	0.00332	CcSEcCtD
Aminoglutethimide—Leukopenia—Vincristine—kidney cancer	0.000698	0.00326	CcSEcCtD
Aminoglutethimide—Pancytopenia—Capecitabine—kidney cancer	0.000692	0.00323	CcSEcCtD
Aminoglutethimide—Body temperature increased—Erlotinib—kidney cancer	0.000687	0.00321	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000685	0.0032	CcSEcCtD
Aminoglutethimide—Anaemia—Gemcitabine—kidney cancer	0.000683	0.00319	CcSEcCtD
Aminoglutethimide—Neutropenia—Capecitabine—kidney cancer	0.000682	0.00318	CcSEcCtD
Aminoglutethimide—Decreased appetite—Sorafenib—kidney cancer	0.000679	0.00317	CcSEcCtD
Aminoglutethimide—Anorexia—Dactinomycin—kidney cancer	0.000679	0.00317	CcSEcCtD
Aminoglutethimide—Nausea—Pazopanib—kidney cancer	0.000677	0.00316	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Vinblastine—kidney cancer	0.000666	0.00311	CcSEcCtD
Aminoglutethimide—Myalgia—Vincristine—kidney cancer	0.000663	0.0031	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Everolimus—kidney cancer	0.000663	0.0031	CcSEcCtD
Aminoglutethimide—Leukopenia—Gemcitabine—kidney cancer	0.000662	0.00309	CcSEcCtD
Aminoglutethimide—Decreased appetite—Sunitinib—kidney cancer	0.000654	0.00305	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000649	0.00303	CcSEcCtD
Aminoglutethimide—Pruritus—Everolimus—kidney cancer	0.000637	0.00297	CcSEcCtD
Aminoglutethimide—Myalgia—Gemcitabine—kidney cancer	0.000629	0.00294	CcSEcCtD
Aminoglutethimide—Urticaria—Sorafenib—kidney cancer	0.000621	0.0029	CcSEcCtD
Aminoglutethimide—Decreased appetite—Dactinomycin—kidney cancer	0.000619	0.00289	CcSEcCtD
Aminoglutethimide—Body temperature increased—Sorafenib—kidney cancer	0.000618	0.00288	CcSEcCtD
Aminoglutethimide—Pruritus—Erlotinib—kidney cancer	0.000615	0.00287	CcSEcCtD
Aminoglutethimide—Agranulocytosis—Capecitabine—kidney cancer	0.000607	0.00283	CcSEcCtD
Aminoglutethimide—Anorexia—Vincristine—kidney cancer	0.000606	0.00283	CcSEcCtD
Aminoglutethimide—Dizziness—Vinblastine—kidney cancer	0.000598	0.00279	CcSEcCtD
Aminoglutethimide—Dizziness—Everolimus—kidney cancer	0.000595	0.00278	CcSEcCtD
Aminoglutethimide—Body temperature increased—Sunitinib—kidney cancer	0.000594	0.00277	CcSEcCtD
Aminoglutethimide—Hypotension—Vincristine—kidney cancer	0.000594	0.00277	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000579	0.0027	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Sorafenib—kidney cancer	0.000576	0.00269	CcSEcCtD
Aminoglutethimide—Anorexia—Gemcitabine—kidney cancer	0.000575	0.00268	CcSEcCtD
Aminoglutethimide—Vomiting—Vinblastine—kidney cancer	0.000575	0.00268	CcSEcCtD
Aminoglutethimide—Dizziness—Erlotinib—kidney cancer	0.000574	0.00268	CcSEcCtD
Aminoglutethimide—Vomiting—Everolimus—kidney cancer	0.000572	0.00267	CcSEcCtD
Aminoglutethimide—Anaemia—Paclitaxel—kidney cancer	0.000572	0.00267	CcSEcCtD
Aminoglutethimide—Rash—Everolimus—kidney cancer	0.000568	0.00265	CcSEcCtD
Aminoglutethimide—Dermatitis—Everolimus—kidney cancer	0.000567	0.00265	CcSEcCtD
Aminoglutethimide—Headache—Vinblastine—kidney cancer	0.000566	0.00264	CcSEcCtD
Aminoglutethimide—Headache—Everolimus—kidney cancer	0.000564	0.00263	CcSEcCtD
Aminoglutethimide—Hypotension—Gemcitabine—kidney cancer	0.000564	0.00263	CcSEcCtD
Aminoglutethimide—Body temperature increased—Dactinomycin—kidney cancer	0.000563	0.00263	CcSEcCtD
Aminoglutethimide—Leukopenia—Paclitaxel—kidney cancer	0.000554	0.00259	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Sunitinib—kidney cancer	0.000554	0.00259	CcSEcCtD
Aminoglutethimide—Decreased appetite—Vincristine—kidney cancer	0.000553	0.00258	CcSEcCtD
Aminoglutethimide—Pruritus—Sorafenib—kidney cancer	0.000553	0.00258	CcSEcCtD
Aminoglutethimide—Vomiting—Erlotinib—kidney cancer	0.000552	0.00258	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.00055	0.00257	CcSEcCtD
Aminoglutethimide—Rash—Erlotinib—kidney cancer	0.000548	0.00256	CcSEcCtD
Aminoglutethimide—Dermatitis—Erlotinib—kidney cancer	0.000547	0.00255	CcSEcCtD
Aminoglutethimide—Headache—Erlotinib—kidney cancer	0.000544	0.00254	CcSEcCtD
Aminoglutethimide—Nausea—Vinblastine—kidney cancer	0.000537	0.00251	CcSEcCtD
Aminoglutethimide—Somnolence—Gemcitabine—kidney cancer	0.000536	0.0025	CcSEcCtD
Aminoglutethimide—Nausea—Everolimus—kidney cancer	0.000535	0.0025	CcSEcCtD
Aminoglutethimide—Pruritus—Sunitinib—kidney cancer	0.000532	0.00248	CcSEcCtD
Aminoglutethimide—Myalgia—Paclitaxel—kidney cancer	0.000527	0.00246	CcSEcCtD
Aminoglutethimide—Decreased appetite—Gemcitabine—kidney cancer	0.000524	0.00245	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Dactinomycin—kidney cancer	0.000524	0.00245	CcSEcCtD
Aminoglutethimide—Dizziness—Sorafenib—kidney cancer	0.000517	0.00241	CcSEcCtD
Aminoglutethimide—Nausea—Erlotinib—kidney cancer	0.000516	0.00241	CcSEcCtD
Aminoglutethimide—Body temperature increased—Vincristine—kidney cancer	0.000503	0.00235	CcSEcCtD
Aminoglutethimide—Dizziness—Sunitinib—kidney cancer	0.000497	0.00232	CcSEcCtD
Aminoglutethimide—Vomiting—Sorafenib—kidney cancer	0.000497	0.00232	CcSEcCtD
Aminoglutethimide—Tachycardia—Paclitaxel—kidney cancer	0.000493	0.0023	CcSEcCtD
Aminoglutethimide—Rash—Sorafenib—kidney cancer	0.000493	0.0023	CcSEcCtD
Aminoglutethimide—Dermatitis—Sorafenib—kidney cancer	0.000492	0.0023	CcSEcCtD
Aminoglutethimide—Headache—Sorafenib—kidney cancer	0.00049	0.00229	CcSEcCtD
Aminoglutethimide—Anorexia—Paclitaxel—kidney cancer	0.000481	0.00225	CcSEcCtD
Aminoglutethimide—Vomiting—Sunitinib—kidney cancer	0.000478	0.00223	CcSEcCtD
Aminoglutethimide—Body temperature increased—Gemcitabine—kidney cancer	0.000477	0.00223	CcSEcCtD
Aminoglutethimide—Rash—Sunitinib—kidney cancer	0.000474	0.00221	CcSEcCtD
Aminoglutethimide—Dermatitis—Sunitinib—kidney cancer	0.000474	0.00221	CcSEcCtD
Aminoglutethimide—Hypotension—Paclitaxel—kidney cancer	0.000472	0.0022	CcSEcCtD
Aminoglutethimide—Headache—Sunitinib—kidney cancer	0.000471	0.0022	CcSEcCtD
Aminoglutethimide—Anaemia—Capecitabine—kidney cancer	0.000469	0.00219	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Vincristine—kidney cancer	0.000469	0.00219	CcSEcCtD
Aminoglutethimide—Nausea—Sorafenib—kidney cancer	0.000464	0.00217	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.00046	0.00215	CcSEcCtD
Aminoglutethimide—Leukopenia—Capecitabine—kidney cancer	0.000455	0.00212	CcSEcCtD
Aminoglutethimide—Vomiting—Dactinomycin—kidney cancer	0.000453	0.00211	CcSEcCtD
Aminoglutethimide—Somnolence—Paclitaxel—kidney cancer	0.000449	0.0021	CcSEcCtD
Aminoglutethimide—Rash—Dactinomycin—kidney cancer	0.000449	0.0021	CcSEcCtD
Aminoglutethimide—Nausea—Sunitinib—kidney cancer	0.000447	0.00208	CcSEcCtD
Aminoglutethimide—Pancytopenia—Doxorubicin—kidney cancer	0.000446	0.00208	CcSEcCtD
Aminoglutethimide—Neutropenia—Doxorubicin—kidney cancer	0.000439	0.00205	CcSEcCtD
Aminoglutethimide—Decreased appetite—Paclitaxel—kidney cancer	0.000439	0.00205	CcSEcCtD
Aminoglutethimide—Myalgia—Capecitabine—kidney cancer	0.000432	0.00202	CcSEcCtD
Aminoglutethimide—Pruritus—Gemcitabine—kidney cancer	0.000427	0.00199	CcSEcCtD
Aminoglutethimide—Nausea—Dactinomycin—kidney cancer	0.000423	0.00197	CcSEcCtD
Aminoglutethimide—Dizziness—Vincristine—kidney cancer	0.000421	0.00196	CcSEcCtD
Aminoglutethimide—Drowsiness—Doxorubicin—kidney cancer	0.000419	0.00196	CcSEcCtD
Aminoglutethimide—Tachycardia—Capecitabine—kidney cancer	0.000405	0.00189	CcSEcCtD
Aminoglutethimide—Vomiting—Vincristine—kidney cancer	0.000404	0.00189	CcSEcCtD
Aminoglutethimide—Urticaria—Paclitaxel—kidney cancer	0.000401	0.00187	CcSEcCtD
Aminoglutethimide—Rash—Vincristine—kidney cancer	0.000401	0.00187	CcSEcCtD
Aminoglutethimide—Dermatitis—Vincristine—kidney cancer	0.000401	0.00187	CcSEcCtD
Aminoglutethimide—Body temperature increased—Paclitaxel—kidney cancer	0.000399	0.00186	CcSEcCtD
Aminoglutethimide—Headache—Vincristine—kidney cancer	0.000398	0.00186	CcSEcCtD
Aminoglutethimide—Anorexia—Capecitabine—kidney cancer	0.000395	0.00184	CcSEcCtD
Aminoglutethimide—Agranulocytosis—Doxorubicin—kidney cancer	0.000391	0.00183	CcSEcCtD
Aminoglutethimide—Hypotension—Capecitabine—kidney cancer	0.000387	0.00181	CcSEcCtD
Aminoglutethimide—Vomiting—Gemcitabine—kidney cancer	0.000384	0.00179	CcSEcCtD
Aminoglutethimide—Rash—Gemcitabine—kidney cancer	0.00038	0.00178	CcSEcCtD
Aminoglutethimide—Dermatitis—Gemcitabine—kidney cancer	0.00038	0.00177	CcSEcCtD
Aminoglutethimide—Headache—Gemcitabine—kidney cancer	0.000378	0.00176	CcSEcCtD
Aminoglutethimide—Nausea—Vincristine—kidney cancer	0.000378	0.00176	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000378	0.00176	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Paclitaxel—kidney cancer	0.000372	0.00174	CcSEcCtD
Aminoglutethimide—Decreased appetite—Capecitabine—kidney cancer	0.00036	0.00168	CcSEcCtD
Aminoglutethimide—Nausea—Gemcitabine—kidney cancer	0.000358	0.00167	CcSEcCtD
Aminoglutethimide—Pruritus—Paclitaxel—kidney cancer	0.000357	0.00167	CcSEcCtD
Aminoglutethimide—Dizziness—Paclitaxel—kidney cancer	0.000334	0.00156	CcSEcCtD
Aminoglutethimide—Urticaria—Capecitabine—kidney cancer	0.000329	0.00154	CcSEcCtD
Aminoglutethimide—Body temperature increased—Capecitabine—kidney cancer	0.000328	0.00153	CcSEcCtD
Aminoglutethimide—Vomiting—Paclitaxel—kidney cancer	0.000321	0.0015	CcSEcCtD
Aminoglutethimide—Rash—Paclitaxel—kidney cancer	0.000318	0.00149	CcSEcCtD
Aminoglutethimide—Dermatitis—Paclitaxel—kidney cancer	0.000318	0.00149	CcSEcCtD
Aminoglutethimide—Headache—Paclitaxel—kidney cancer	0.000316	0.00148	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Capecitabine—kidney cancer	0.000305	0.00143	CcSEcCtD
Aminoglutethimide—Anaemia—Doxorubicin—kidney cancer	0.000303	0.00141	CcSEcCtD
Aminoglutethimide—Nausea—Paclitaxel—kidney cancer	0.0003	0.0014	CcSEcCtD
Aminoglutethimide—Pruritus—Capecitabine—kidney cancer	0.000293	0.00137	CcSEcCtD
Aminoglutethimide—Leukopenia—Doxorubicin—kidney cancer	0.000293	0.00137	CcSEcCtD
Aminoglutethimide—Myalgia—Doxorubicin—kidney cancer	0.000279	0.0013	CcSEcCtD
Aminoglutethimide—Dizziness—Capecitabine—kidney cancer	0.000274	0.00128	CcSEcCtD
Aminoglutethimide—Vomiting—Capecitabine—kidney cancer	0.000264	0.00123	CcSEcCtD
Aminoglutethimide—Rash—Capecitabine—kidney cancer	0.000261	0.00122	CcSEcCtD
Aminoglutethimide—Dermatitis—Capecitabine—kidney cancer	0.000261	0.00122	CcSEcCtD
Aminoglutethimide—Tachycardia—Doxorubicin—kidney cancer	0.000261	0.00122	CcSEcCtD
Aminoglutethimide—Headache—Capecitabine—kidney cancer	0.00026	0.00121	CcSEcCtD
Aminoglutethimide—Anorexia—Doxorubicin—kidney cancer	0.000255	0.00119	CcSEcCtD
Aminoglutethimide—Hypotension—Doxorubicin—kidney cancer	0.00025	0.00117	CcSEcCtD
Aminoglutethimide—Nausea—Capecitabine—kidney cancer	0.000246	0.00115	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000243	0.00114	CcSEcCtD
Aminoglutethimide—Somnolence—Doxorubicin—kidney cancer	0.000238	0.00111	CcSEcCtD
Aminoglutethimide—Decreased appetite—Doxorubicin—kidney cancer	0.000232	0.00108	CcSEcCtD
Aminoglutethimide—Urticaria—Doxorubicin—kidney cancer	0.000212	0.000991	CcSEcCtD
Aminoglutethimide—Body temperature increased—Doxorubicin—kidney cancer	0.000211	0.000986	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Doxorubicin—kidney cancer	0.000197	0.000919	CcSEcCtD
Aminoglutethimide—Pruritus—Doxorubicin—kidney cancer	0.000189	0.000883	CcSEcCtD
Aminoglutethimide—Dizziness—Doxorubicin—kidney cancer	0.000177	0.000825	CcSEcCtD
Aminoglutethimide—Vomiting—Doxorubicin—kidney cancer	0.00017	0.000793	CcSEcCtD
Aminoglutethimide—Rash—Doxorubicin—kidney cancer	0.000168	0.000786	CcSEcCtD
Aminoglutethimide—Dermatitis—Doxorubicin—kidney cancer	0.000168	0.000786	CcSEcCtD
Aminoglutethimide—Headache—Doxorubicin—kidney cancer	0.000167	0.000781	CcSEcCtD
Aminoglutethimide—Nausea—Doxorubicin—kidney cancer	0.000159	0.000741	CcSEcCtD
Aminoglutethimide—CYP11A1—Metabolism—ALDH1A1—kidney cancer	0.000121	0.00133	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000118	0.0013	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—CCBL1—kidney cancer	0.000117	0.00128	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—PGK1—kidney cancer	0.000116	0.00127	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—SLC5A3—kidney cancer	0.000116	0.00127	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—LDHB—kidney cancer	0.000113	0.00125	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Phase II conjugation—GSTM1—kidney cancer	0.000113	0.00124	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000113	0.00124	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000112	0.00124	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000111	0.00122	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—kidney cancer	0.000111	0.00122	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—MTOR—kidney cancer	0.00011	0.00122	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—RELA—kidney cancer	0.00011	0.00121	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.00011	0.00121	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000109	0.0012	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—kidney cancer	0.000107	0.00118	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.000105	0.00116	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Biological oxidations—GSTT1—kidney cancer	0.000104	0.00114	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—kidney cancer	0.000101	0.00112	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—kidney cancer	0.000101	0.00112	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—GLIPR1—kidney cancer	0.000101	0.00111	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—PPAT—kidney cancer	0.000101	0.00111	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Arachidonic acid metabolism—PTGS2—kidney cancer	0.0001	0.0011	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	9.99e-05	0.0011	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—kidney cancer	9.93e-05	0.00109	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—CCND1—kidney cancer	9.89e-05	0.00109	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	9.88e-05	0.00109	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—JUN—kidney cancer	9.87e-05	0.00109	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—CA9—kidney cancer	9.84e-05	0.00108	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—kidney cancer	9.8e-05	0.00108	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Biological oxidations—PTGS1—kidney cancer	9.73e-05	0.00107	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—kidney cancer	9.66e-05	0.00106	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	9.62e-05	0.00106	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—PTEN—kidney cancer	9.55e-05	0.00105	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—APRT—kidney cancer	9.4e-05	0.00103	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—FH—kidney cancer	9.4e-05	0.00103	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Biological oxidations—GSTP1—kidney cancer	9.24e-05	0.00102	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	9.19e-05	0.00101	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metapathway biotransformation—GSTP1—kidney cancer	9.11e-05	0.001	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	9.11e-05	0.001	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—GPC3—kidney cancer	8.84e-05	0.000973	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Phase 1 - Functionalization of compounds—POMC—kidney cancer	8.8e-05	0.000969	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—kidney cancer	8.62e-05	0.000949	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—CA2—kidney cancer	8.6e-05	0.000947	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	8.59e-05	0.000945	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Biological oxidations—GSTM1—kidney cancer	8.49e-05	0.000935	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—kidney cancer	8.44e-05	0.000929	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	8.38e-05	0.000923	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—ALAD—kidney cancer	8.38e-05	0.000922	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metapathway biotransformation—GSTM1—kidney cancer	8.37e-05	0.000922	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—CRABP1—kidney cancer	8.37e-05	0.000921	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—ST3GAL2—kidney cancer	8.18e-05	0.0009	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Biological oxidations—CYP1A1—kidney cancer	8.05e-05	0.000886	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Biological oxidations—GSTT1—kidney cancer	8.02e-05	0.000882	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—ALDH1A1—kidney cancer	7.99e-05	0.00088	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metapathway biotransformation—CYP1A1—kidney cancer	7.94e-05	0.000874	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—MYC—kidney cancer	7.93e-05	0.000873	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—ITPR2—kidney cancer	7.78e-05	0.000856	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—kidney cancer	7.76e-05	0.000855	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—kidney cancer	7.76e-05	0.000854	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—PGK1—kidney cancer	7.66e-05	0.000844	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—SLC5A3—kidney cancer	7.66e-05	0.000844	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	7.6e-05	0.000836	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—LDHB—kidney cancer	7.52e-05	0.000827	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Biological oxidations—PTGS1—kidney cancer	7.51e-05	0.000827	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—KRAS—kidney cancer	7.33e-05	0.000807	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Biological oxidations—GSTP1—kidney cancer	7.2e-05	0.000792	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	7.17e-05	0.00079	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.17e-05	0.000789	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metapathway biotransformation—GSTP1—kidney cancer	7.1e-05	0.000782	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—GSTT1—kidney cancer	7.09e-05	0.000781	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—ACHE—kidney cancer	7.09e-05	0.000781	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—ACY1—kidney cancer	7.08e-05	0.000779	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	6.79e-05	0.000748	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—SCARB1—kidney cancer	6.71e-05	0.000739	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—PTGS1—kidney cancer	6.65e-05	0.000731	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Biological oxidations—GSTM1—kidney cancer	6.62e-05	0.000728	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metapathway biotransformation—GSTM1—kidney cancer	6.53e-05	0.000718	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—PSMD7—kidney cancer	6.52e-05	0.000717	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—CA9—kidney cancer	6.52e-05	0.000717	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—TP53—kidney cancer	6.52e-05	0.000717	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	6.37e-05	0.000701	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Biological oxidations—CYP1A1—kidney cancer	6.27e-05	0.00069	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metapathway biotransformation—CYP1A1—kidney cancer	6.19e-05	0.000681	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—BCHE—kidney cancer	6.18e-05	0.00068	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—SLC5A5—kidney cancer	6.1e-05	0.000672	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	6.04e-05	0.000665	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—PDHB—kidney cancer	6.02e-05	0.000663	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Biological oxidations—POMC—kidney cancer	6e-05	0.000661	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—SLC2A1—kidney cancer	5.89e-05	0.000649	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.72e-05	0.000629	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—CCBL1—kidney cancer	5.66e-05	0.000623	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Biological oxidations—GSTP1—kidney cancer	5.56e-05	0.000612	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—CRABP1—kidney cancer	5.54e-05	0.00061	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—ACY1—kidney cancer	5.52e-05	0.000607	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	5.48e-05	0.000603	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—ITPR2—kidney cancer	5.15e-05	0.000567	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	5.12e-05	0.000563	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Biological oxidations—GSTM1—kidney cancer	5.11e-05	0.000562	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	5.04e-05	0.000554	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.99e-05	0.000549	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—GSTP1—kidney cancer	4.92e-05	0.000541	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—GLIPR1—kidney cancer	4.91e-05	0.00054	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—PPAT—kidney cancer	4.91e-05	0.00054	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	4.85e-05	0.000533	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	4.84e-05	0.000533	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	4.8e-05	0.000528	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	4.77e-05	0.000525	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.75e-05	0.000523	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	4.7e-05	0.000518	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—GSTT1—kidney cancer	4.7e-05	0.000517	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—ACHE—kidney cancer	4.7e-05	0.000517	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—PDHB—kidney cancer	4.69e-05	0.000516	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Biological oxidations—POMC—kidney cancer	4.68e-05	0.000515	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—ABCB1—kidney cancer	4.65e-05	0.000512	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—FH—kidney cancer	4.56e-05	0.000502	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—APRT—kidney cancer	4.56e-05	0.000502	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—GSTM1—kidney cancer	4.52e-05	0.000497	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	4.46e-05	0.000491	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—SCARB1—kidney cancer	4.45e-05	0.000489	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—CCBL1—kidney cancer	4.41e-05	0.000485	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—PTGS1—kidney cancer	4.4e-05	0.000485	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—PSMD7—kidney cancer	4.32e-05	0.000475	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—GPC3—kidney cancer	4.29e-05	0.000472	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—CYP1A1—kidney cancer	4.28e-05	0.000471	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—ACY1—kidney cancer	4.26e-05	0.000469	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—CA2—kidney cancer	4.17e-05	0.000459	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—BCHE—kidney cancer	4.09e-05	0.00045	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—ALAD—kidney cancer	4.07e-05	0.000448	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—SLC5A5—kidney cancer	4.04e-05	0.000445	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.99e-05	0.000439	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—ST3GAL2—kidney cancer	3.97e-05	0.000437	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—SLC2A1—kidney cancer	3.9e-05	0.00043	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—ALDH1A1—kidney cancer	3.88e-05	0.000427	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—GLIPR1—kidney cancer	3.82e-05	0.000421	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—PPAT—kidney cancer	3.82e-05	0.000421	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.79e-05	0.000417	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.78e-05	0.000416	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.74e-05	0.000411	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—PGK1—kidney cancer	3.72e-05	0.000409	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—SLC5A3—kidney cancer	3.72e-05	0.000409	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—LDHB—kidney cancer	3.65e-05	0.000401	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—PDHB—kidney cancer	3.62e-05	0.000399	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Biological oxidations—POMC—kidney cancer	3.61e-05	0.000397	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—FH—kidney cancer	3.56e-05	0.000391	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—APRT—kidney cancer	3.56e-05	0.000391	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.52e-05	0.000387	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.47e-05	0.000382	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—CCBL1—kidney cancer	3.4e-05	0.000375	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—GPC3—kidney cancer	3.34e-05	0.000368	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.3e-05	0.000364	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—GSTP1—kidney cancer	3.26e-05	0.000358	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—CA2—kidney cancer	3.25e-05	0.000358	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—POMC—kidney cancer	3.19e-05	0.000351	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—ALAD—kidney cancer	3.17e-05	0.000349	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—CA9—kidney cancer	3.16e-05	0.000348	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—ST3GAL2—kidney cancer	3.09e-05	0.00034	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.09e-05	0.00034	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—ABCB1—kidney cancer	3.08e-05	0.000339	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—ALDH1A1—kidney cancer	3.02e-05	0.000333	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—GSTM1—kidney cancer	2.99e-05	0.000329	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—GLIPR1—kidney cancer	2.95e-05	0.000325	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—PPAT—kidney cancer	2.95e-05	0.000325	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—PGK1—kidney cancer	2.9e-05	0.000319	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—SLC5A3—kidney cancer	2.9e-05	0.000319	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—LDHB—kidney cancer	2.84e-05	0.000313	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—CYP1A1—kidney cancer	2.84e-05	0.000312	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—FH—kidney cancer	2.74e-05	0.000302	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—APRT—kidney cancer	2.74e-05	0.000302	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—CRABP1—kidney cancer	2.69e-05	0.000296	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—GPC3—kidney cancer	2.58e-05	0.000284	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—PTGS2—kidney cancer	2.55e-05	0.00028	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—CA2—kidney cancer	2.51e-05	0.000276	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—ITPR2—kidney cancer	2.5e-05	0.000275	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—CA9—kidney cancer	2.46e-05	0.000271	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—ALAD—kidney cancer	2.45e-05	0.000269	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.41e-05	0.000265	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—ST3GAL2—kidney cancer	2.39e-05	0.000263	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—ALDH1A1—kidney cancer	2.33e-05	0.000257	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.33e-05	0.000257	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.3e-05	0.000254	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—GSTT1—kidney cancer	2.28e-05	0.000251	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—ACHE—kidney cancer	2.28e-05	0.000251	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—PGK1—kidney cancer	2.24e-05	0.000246	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—SLC5A3—kidney cancer	2.24e-05	0.000246	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—PTEN—kidney cancer	2.22e-05	0.000244	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—LDHB—kidney cancer	2.19e-05	0.000241	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—SCARB1—kidney cancer	2.16e-05	0.000238	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—PTGS1—kidney cancer	2.14e-05	0.000235	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—POMC—kidney cancer	2.11e-05	0.000233	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—CRABP1—kidney cancer	2.1e-05	0.000231	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—PSMD7—kidney cancer	2.09e-05	0.000231	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—BCHE—kidney cancer	1.99e-05	0.000219	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—SLC5A5—kidney cancer	1.96e-05	0.000216	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—ITPR2—kidney cancer	1.95e-05	0.000214	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—CA9—kidney cancer	1.9e-05	0.000209	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—SLC2A1—kidney cancer	1.89e-05	0.000209	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.84e-05	0.000202	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.8e-05	0.000198	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—ACHE—kidney cancer	1.78e-05	0.000196	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—GSTT1—kidney cancer	1.78e-05	0.000196	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—PTGS2—kidney cancer	1.69e-05	0.000186	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—SCARB1—kidney cancer	1.68e-05	0.000185	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—PTGS1—kidney cancer	1.66e-05	0.000183	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—PSMD7—kidney cancer	1.63e-05	0.00018	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—CRABP1—kidney cancer	1.62e-05	0.000178	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.6e-05	0.000176	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—GSTP1—kidney cancer	1.58e-05	0.000174	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—PIK3CA—kidney cancer	1.57e-05	0.000172	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—BCHE—kidney cancer	1.55e-05	0.00017	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—SLC5A5—kidney cancer	1.53e-05	0.000168	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—ITPR2—kidney cancer	1.5e-05	0.000165	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—ABCB1—kidney cancer	1.5e-05	0.000165	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—SLC2A1—kidney cancer	1.48e-05	0.000162	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—PTEN—kidney cancer	1.47e-05	0.000162	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—GSTM1—kidney cancer	1.45e-05	0.00016	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.43e-05	0.000158	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—CYP1A1—kidney cancer	1.38e-05	0.000152	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—ACHE—kidney cancer	1.37e-05	0.000151	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—GSTT1—kidney cancer	1.37e-05	0.000151	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—SCARB1—kidney cancer	1.3e-05	0.000143	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—PTGS1—kidney cancer	1.28e-05	0.000141	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—PSMD7—kidney cancer	1.26e-05	0.000139	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.25e-05	0.000137	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—GSTP1—kidney cancer	1.23e-05	0.000136	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—BCHE—kidney cancer	1.19e-05	0.000131	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.18e-05	0.00013	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—ABCB1—kidney cancer	1.17e-05	0.000128	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.14e-05	0.000125	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—GSTM1—kidney cancer	1.13e-05	0.000125	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.13e-05	0.000124	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—CYP1A1—kidney cancer	1.07e-05	0.000118	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—PIK3CA—kidney cancer	1.04e-05	0.000114	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—POMC—kidney cancer	1.03e-05	0.000113	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—GSTP1—kidney cancer	9.5e-06	0.000105	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—ABCB1—kidney cancer	8.99e-06	9.9e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.81e-06	9.7e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—GSTM1—kidney cancer	8.73e-06	9.61e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—CYP1A1—kidney cancer	8.28e-06	9.11e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—PTGS2—kidney cancer	8.19e-06	9.01e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—POMC—kidney cancer	8e-06	8.8e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—PTEN—kidney cancer	7.14e-06	7.86e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—PTGS2—kidney cancer	6.38e-06	7.02e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—POMC—kidney cancer	6.17e-06	6.79e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—PTEN—kidney cancer	5.56e-06	6.12e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—PIK3CA—kidney cancer	5.04e-06	5.54e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—PTGS2—kidney cancer	4.92e-06	5.42e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—PTEN—kidney cancer	4.29e-06	4.73e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—PIK3CA—kidney cancer	3.92e-06	4.32e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—PIK3CA—kidney cancer	3.03e-06	3.33e-05	CbGpPWpGaD
